October 2003 :: Vol 33 No 10
Clinical and prevention
Akahane, A. and Nanko, S. (2003) Pathogenesis and heterogeneity in schizophrenia. [Review] [13 refs] [Japanese]. Ryoikibetsu Shokogun Shirizu. (38), 25-9
Anonymous (2003) FluMist: an intranasal live influenza vaccine. Medical Letter on Drugs & Therapeutics. vol. 45(1163), 65-6
Anonymous (2003) SARS vs. flu: can you tell serious disease from common malady? Ed Management. vol. 15(9), 97-100
Anonymous (2003) Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.[original report in Ann Intern Med. 2003 Sep 2;139(5 Pt 1):321-9; PMID: 12965940]. Annals of Internal Medicine. vol. 139(5 Pt 1), I27
Bradbury, J. (2003) Custom-made vaccines at speed. Drug Discovery Today. vol. 8(12), 518-9
Brydak, L. B. (2003) [The monitoring of influenza vaccination programs in Poland and European Union]. [Review] [49 refs] [Polish]. Przeglad Epidemiologiczny. vol. 57 (Suppl 1), 69-81
Centers for Disease Control and Prevention (CDC) (2003) Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or =65 years--United States, 1989-2001. MMWR. Morbidity & Mortality Weekly Report. vol. 52(40), 958-62
Centers for Disease Control and Prevention (CDC) (2003) Update: influenza activity--United States and worldwide, May-September 2003. MMWR. Morbidity & Mortality Weekly Report. vol. 52(38), 911-3
Donalisio, M. R., Ramalheira, R. M., and Cordeiro, R. (2003) [Adverse reactions to influenza vaccine in the elderly, Campinas District, SP, 2000]. [Portuguese]. Revista Da Sociedade Brasileira de Medicina Tropical. vol. 36(4), 467-71
Drinka, P. J., Krause, P., and Nest, L. (2003) Clinical features of influenza a virus infection in older hospitalized persons.[comment]. Journal of the American Geriatrics Society. vol. 51(8), 1184
Duchini, A., Goss, J. A., Karpen, S., and Pockros, P. J. (2003) Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. [Review] [104 refs]. Clinical Microbiology Reviews. vol. 16(3), 357-64
Eisner, M. D. (2003) Asthma and influenza vaccination.[comment]. Chest. vol. 124(3), 775-7
Ellerbeck, E. F., Totten, B., Markello, S., Patterson, K., Sipe, T. R., and Tilden, C. (2003) Quality improvement in critical access hospitals: addressing immunizations prior to discharge. Journal of Rural Health. vol. 19(4), 433-8
Ford, E. S., Mannino, D. M., and Williams, S. G. (2003) Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys.[comment]. Chest. vol. 124(3), 783-9
Forleo-Neto, E., Halker, E., Santos, V. J., Paiva, T. M., and Toniolo-Neto, J. (2003) [Influenza]. [Review] [51 refs] [Portuguese]. Revista Da Sociedade Brasileira de Medicina Tropical. vol. 36(2), 267-74
Granier, H., Nicolas, X., Laborde, J. P., and Talarmin, F. (2003) [Severe autoimmune thrombopenia following anti-influenza vaccination]. [French]. Presse Medicale. vol. 32(26), 1223-4
Greenko, J., Mostashari, F., Fine, A., and Layton, M. (2003) Clinical evaluation of the Emergency Medical Services (EMS) ambulance dispatch-based syndromic surveillance system, New York City. Journal of Urban Health. vol. 80(2 Suppl 1), i50-6
Harper, S. A., Fukuda, K., Cox, N. J., Bridges, C. B., and Advisory Committeeo. n. = Immunization Practices (2003) Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report. Recommendations & Reports. vol. 52(RR-13), 1-8
Imuta, F., Toyoda, M., and Toyoda, T. (2003) New application method of zanamivir with a straw. Pediatrics International. vol. 45(3), 366-7
Kassianos, G. (2003) Influenza vaccination of patients receiving cytotoxic chemotherapy: can we do better?[comment]. International Journal of Clinical Practice. vol. 57(6), 457-8
Kawashima, H., Watanabe, Y., Morishima, T., Togashi, T., Yamada, N., Kashiwagi, Y., Takekuma, K., Hoshika, A., and Mori, T. (2003) NOx (nitrite/nitrate) in cerebral spinal fluids obtained from patients with influenza-associated encephalopathy. Neuropediatrics. vol. 34(3), 137-40
Khater, F. and Moorman, J. P. (2003) Complications of influenza. [Review] [38 refs]. Southern Medical Journal. vol. 96(8), 740-3
Kolbe, F., Sitar, D. S., Papaioannou, A., and Campbell, G. (2003) An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients. Canadian Journal of Clinical Pharmacology. vol. 10(3), 119-22
Kumar, P., Sharma, S., Khanna, M., and Raj, H. G. (2003) Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. International Journal of Experimental Pathology. vol. 84(3), 127-33
Lee, P. P. (2003) Prevention and control of influenza. [Review] [38 refs]. Southern Medical Journal. vol. 96(8), 751-7
Levenson, D. (2003) Flu treatment for the elderly makes economic sense, study says. Report on Medical Guidelines & Outcomes Research. vol. 14(18), 1
Matheson, N. J., Symmonds-Abrahams, M., Sheikh, A., Shepperd, S., and Harnden, A. (2003) Neuraminidase inhibitors for preventing and treating influenza in children. [Review] [44 refs]. Cochrane Database of Systematic Reviews. (3), CD002744
Myers, J. W. (2003) Influenza therapy. [Review] [47 refs]. Southern Medical Journal. vol. 96(8), 744-50
National Advisory Committee on Immunization (2003) An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season. Canada Communicable Disease Report. vol. 29, 1-20
Postma, M. J., Heijnen, M. A., de Vries, R., Beutels, P., and Jager, J. C. (2003) [Splenectomy and pneumococcal vaccination].[comment]. [Dutch]. Nederlands Tijdschrift voor Geneeskunde. vol. 147(23), 1141-2; author reply 1142
Prior, L. (2003) Belief, knowledge and expertise: the emergence of the lay expert in medical sociology. [Review] [52 refs]. Sociology of Health & Illness. vol. 25, 41-57
Ring, A., Marx, G., Steer, C., Prendiville, J., and Ellis, P. (2003) Poor uptake of influenza vaccinations in patients receiving cytotoxic chemotherapy.[comment]. International Journal of Clinical Practice. vol. 57(6), 542-3
Sarria-Santamera, A. and Timoner, J. (2003) Influenza vaccination in old adults in Spain. European Journal of Public Health. vol. 13(2), 133-7
Sarubbi, F. A. (2003) Influenza: a historical perspective. Southern Medical Journal. vol. 96(8), 735-6
Sarubbi, F. A. (2003) Influenza. Introduction. Southern Medical Journal. vol. 96(8), 734
Schurch, J. and Mayr, M. (2003) [Non-specific influenza symptoms and microhematuria. IgA nephritis/Berger disease]. [German]. Schweizerische Rundschau fur Medizin Praxis. vol. 92(17), 823-5
Shorman, M. and Moorman, J. P. (2003) Clinical manifestations and diagnosis of influenza. [Review] [25 refs]. Southern Medical Journal. vol. 96(8), 737-9
Soldo, I., Duvnjak, M., Lisnjic, D., Timarac, J., Peric, L., Palic, R., Vranjes, Z., and Soldo-Butkovic, S. (2003) Encephalitis or encephalopathy during an influenza-A epidemic. Collegium Antropologicum. vol. 27(Suppl 1), 19-22
Szilagyi, P. G., Iwane, M. K., Schaffer, S., Humiston, S. G., Barth, R., McInerny, T., Shone, L., and Schwartz, B. (2003) Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics. vol. 112(4), 821-8
Tata, L. J., West, J., Harrison, T., Farrington, P., Smith, C., and Hubbard, R. (2003) Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax. vol. 58(10), 835-9
Vastag, B. (2003) Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS. JAMA. vol. 290(13), 1695-6
Wongsurakiat, P., Lertakyamanee, J., Maranetra, K. N., Jongriratanakul, S., and Sangkaew, S. (2003) Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. Journal of the Medical Association of Thailand. vol. 86(6), 497-508
Epidemiology
Afkhami, A. (2003) Compromised constitutions: the Iranian experience with the 1918 influenza pandemic. Bulletin of the History of Medicine. vol. 77(2), 367-92
Aguilera, J. F., Paget, W. J., Mosnier, A., Heijnen, M. L., Uphoff, H., van, d. e. r. Velden J, Vega, T., and Watson, J. M. (2003) Heterogeneous case definitions used for the surveillance of influenza in Europe.[comment]. European Journal of Epidemiology. vol. 18(8), 751-4
Anonymous (2003) Influenza prevention 2003-2004. Medical Letter on Drugs & Therapeutics. vol. 45(1166), 78-80
Centers for Disease Control and Prevention (CDC) (2003) Public health and aging: influenza vaccination coverage among adults aged > or =50 years and pneumococcal vaccination coverage among adults aged > or =65 years--United States, 2002. MMWR. Morbidity & Mortality Weekly Report. vol. 52(41), 987-92
Hannoun, C. (2003) Case definition for influenza surveillance.[comment]. European Journal of Epidemiology. vol. 18(8), 737-8
Hulsen, J. (2003) [A new product in the vaccination gap: the vector vaccine. Merial introduced an innovative influenza-tetanus vaccine for horses]. [Dutch]. Tijdschrift voor Diergeneeskunde. vol. 128(9), 295-6
Marsden, A. G. (2003) Influenza outbreak related to air travel. Medical Journal of Australia. vol. 179(3), 172-3
Mostashari, F., Fine, A., Das, D., Adams, J., and Layton, M. (2003) Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City. Journal of Urban Health. vol. 80(2 Suppl 1), i43-9
Qiao, C. L., Yu, K. Z., Jiang, Y. P., Jia, Y. Q., Tian, G. B., Liu, M., Deng, G. H., Wang, X. R., Meng, Q. W., and Tang, X. Y. (2003) Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathology. vol. 32(1), 25-32
Rao, B. L. (2003) Epidemiology and control of influenza. [Review] [65 refs]. National Medical Journal of India. vol. 16(3), 143-9
Uphoff, H., Cohen, J. M., Fleming, D., and Noone, A. (2003) Harmonisation of national influenza surveillance morbidity data from EISS: a simple index. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. vol. 8(7), 156-64
Urashima, M., Shindo, N., and Okabe, N. (2003) A seasonal model to simulate influenza oscillation in Tokyo. Japanese Journal of Infectious Diseases. vol. 56(2), 43-7
Yohannes, K., Roche, P., Spencer, J., and Hampson, A. (2003) Annual report of the National Influenza Surveillance Scheme, 2002. Communicable Diseases Intelligence. vol. 27(2), 162-72
Immunology
Campos, M. and Godson, D. L. (2003) The effectiveness and limitations of immune memory: understanding protective immune responses. [Review] [73 refs]. International Journal for Parasitology. vol. 33(5-6), 655-61
Chen, H. D., Fraire, A. E., Joris, I., Welsh, R. M., and Selin, L. K. (2003) Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. American Journal of Pathology. vol. 163(4), 1341-55
Coates, P. T., Barratt-Boyes, S. M., Zhang, L., Donnenberg, V. S., O'Connell, P. J., Logar, A. J., Duncan, F. J., Murphey-Corb, M., Donnenberg, A. D., Morelli, A. E., Maliszewski, C. R., and Thomson, A. W. (2003) Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood. vol. 102(7), 2513-21
Crowe, S. R., Turner, S. J., Miller, S. C., Roberts, A. D., Rappolo, R. A., Doherty, P. C., Ely, K. H., and Woodland, D. L. (2003) Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. Journal of Experimental Medicine. vol. 198(3), 399-410
Deem, M. W. and Lee, H. Y. (2003) Sequence space localization in the immune system response to vaccination and disease. Physical Review Letters. vol. 91(6), 068101
Kelly, D. L., Zito, M. A., and Weber, D. (2003) Using a stage model of behavior change to prompt action in an immunization project. Joint Commission Journal on Quality & Safety. vol. 29(6), 321-3
Wales, J., Baird, M., Davies, N., and Buchan, G. (2003) Fusion of interleukin-2 to subunit antigens increase their antigenicity in vitro due to an interleukin-2 receptor beta-mediated antigen uptake mechanism. Scandinavian Journal of Immunology. vol. 58(3), 367-73
Structure, function and genetics
Flandorfer, A., Garcia-Sastre, A., Basler, C. F., and Palese, P. (2003) Chimeric influenza A viruses with a functional influenza B virus neuraminidase or hemagglutinin. Journal of Virology. vol. 77(17), 9116-23
Fujii, Y., Watanabe, T., Horimoto, T., and Kawaoka, Y. (2003) The enigma of influenza virus genome packaging revealed. [Review] [10 refs] [Japanese]. Tanpakushitsu Kakusan Koso - Protein, Nucleic Acid, Enzyme. vol. 48(10), 1357-63
Moorman, J. P. (2003) Viral characteristics of influenza. [Review] [40 refs]. Southern Medical Journal. vol. 96(8), 758-61
Nieva, J. L. and Agirre, A. (2003) Are fusion peptides a good model to study viral cell fusion?. [Review] [110 refs]. Biochimica et Biophysica Acta. vol. 1614(1), 104-15
Padron, D., Wang, Y. J., Yamamoto, M., Yin, H., and Roth, M. G. (2003) Phosphatidylinositol phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. Journal of Cell Biology. vol. 162(4), 693-701
Watanabe, T., Watanabe, S., Noda, T., Fujii, Y., and Kawaoka, Y. (2003) Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. Journal of Virology. vol. 77(19), 10575-83